Oral Oncology, Год журнала: 2024, Номер 154, С. 106835 - 106835
Опубликована: Май 11, 2024
Язык: Английский
Oral Oncology, Год журнала: 2024, Номер 154, С. 106835 - 106835
Опубликована: Май 11, 2024
Язык: Английский
Cells, Год журнала: 2025, Номер 14(2), С. 145 - 145
Опубликована: Янв. 20, 2025
Maxillofacial bone defects can have a profound impact on both facial function and aesthetics. While various biomaterial scaffolds shown promise in addressing these challenges, regenerating this region remains complex due to its irregular shape, intricate structure, differing cellular origins compared other bones the human body. Moreover, significant variable mechanical loads placed maxillofacial add further complexity, especially cases of difficult-to-treat medical conditions. This review provides brief overview medication-related osteonecrosis jaw (MRONJ), highlighting medication-induced adverse reactions associated clinical challenges treating condition. The purpose manuscript is emphasize role biotechnology tissue engineering technologies therapy. By using scaffold materials biofactors combination with autologous cells, innovative solutions are explored for repair damaged bones. ongoing search effective that address improve vitro preparation subsequent regeneration critical. primary spotlight current research trends novel approaches area.
Язык: Английский
Процитировано
0Oral Oncology, Год журнала: 2024, Номер 154, С. 106835 - 106835
Опубликована: Май 11, 2024
Язык: Английский
Процитировано
1